HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R01 Clinical Trial Optional)
ID: 350295Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350295

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-067.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of substance use preventive services. This initiative seeks applications for research that addresses the gap between research and practice in substance misuse prevention, focusing on developing sustainable and effective service delivery strategies. Given the ongoing opioid crisis, the importance of this research is underscored by the need for innovative approaches to integrate evidence-based prevention within existing systems and to enhance workforce capacity. Successful applications may receive funding of up to $4.65 million over a maximum project period of five years, with direct costs not exceeding $800,000 per year. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with the application deadline set for January 16, 2026.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DA-24-067-Full-Announcement.html
    RFA-DA-24-067.html
    The Department of Health and Human Services (HHS) is announcing a funding opportunity under the NIH HEAL Initiative focused on enhancing the implementation of substance use preventive services. The National Institutes of Health (NIH) seeks applications to address the research-to-practice gap in substance misuse prevention, emphasizing strategies for sustainability and effective service delivery. This initiative invites studies with preliminary data to advance infrastructure for ongoing prevention services, especially amidst the ongoing opioid crisis. Key research areas include developing approaches for integrating evidence-based prevention within existing systems (e.g., healthcare), enhancing workforce capacity, and optimizing implementation strategies using innovative technologies. Applicants should engage end-users throughout the research process to ensure relevance and facilitate broader applicability of findings. Funding of up to $4.65 million is available for successful applications that align with established public health objectives. The maximum project period is set at five years, with direct costs recommended not to exceed $800,000 per year. Applications must comply with NIH submission guidelines, including a required Data Management and Sharing Plan. This funding opportunity underscores the NIH’s commitment to improving public health through robust research that informs substance misuse prevention strategies across diverse populations and settings.
    Similar Opportunities
    HEAL Initiative: Research to Increase Implementation of Substance Use Preventive Services (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity under the HEAL Initiative aimed at enhancing the implementation of preventive services for substance use disorders, specifically focusing on opioid misuse. This initiative invites applications for research that addresses gaps in the dissemination and implementation of prevention services, with a phased R61/R33 award mechanism allowing for up to six years of support, contingent on the successful completion of preliminary milestones. The overarching goal is to establish a sustainable prevention infrastructure that effectively reduces risks associated with substance use, emphasizing equity and community involvement in the research process. Interested applicants can find more information and apply by the deadline of January 16, 2026, with a projected funding amount of $4.65 million for the 2024 fiscal year. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-066.html.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HEAL Initiative: Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-054), aimed at supporting innovative research that bridges the gap between research findings and practical applications to combat the opioid overdose crisis. This initiative emphasizes the need for stigma-free, patient-centered care systems and focuses on understudied areas related to overdose prevention, requiring applicants to present preliminary data for significant projects within a maximum project period of five years and a budget of up to $750,000 in direct costs annually. The funding reflects a commitment to addressing health disparities and promoting effective addiction treatment and recovery solutions, with applications evaluated based on significance, innovation, feasibility, and stakeholder engagement. Interested applicants should note that the application deadline is March 20, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the HEAL Initiative funding opportunity titled "Translating Research to Practice to End the Overdose Crisis" (RFA-DA-23-053). This initiative aims to support research that translates findings into actionable practices to combat the ongoing overdose crisis in the U.S., with a focus on developing innovative, scalable, and equitable strategies for patient-centered care in addiction treatment. The funding mechanism allows for projects to span up to six years, divided into a two-year planning phase (R61) and a five-year implementation phase (R33), with an anticipated total funding of up to $15 million based on the quality of applications received. Interested applicants can find more details and submission guidelines at the provided link and should direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov. The application deadline is March 20, 2025.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01), aimed at supporting early career researchers in developing expertise in implementation science related to substance use treatment and prevention. Applicants are required to conduct an independent clinical trial that applies implementation science to one of the four priority domains of the HHS Overdose Prevention Strategy, which includes prevention, treatment, harm reduction, and recovery support services. This initiative is crucial in addressing the ongoing overdose crisis by promoting the integration of evidence-based practices into routine care, fostering a diverse research community, and ensuring equitable access to effective treatment resources. The funding amount is approximately $1.1 million for FY2023, with awards anticipated for 3-5 years of research, and applications are due by November 12, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a grant opportunity titled the HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23), aimed at supporting early career researchers and clinicians in the field of addiction. Applicants are required to have clinical training and must propose an independent clinical trial that aligns with the HHS Overdose Prevention Strategy, focusing on areas such as opioid misuse prevention, treatment, harm reduction, and recovery support services. This initiative is crucial for addressing the ongoing substance use crisis by fostering a new generation of implementation researchers who can effectively translate research into clinical practice. Interested applicants can find more information and apply by November 12, 2025, with funding support of up to $100,000 per year for salary and additional research costs. For inquiries, contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov or visit the opportunity's webpage at http://grants.nih.gov/grants/guide/pa-files/PAS-22-207.html.
    HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional), aimed at addressing substance use disorder (SUD) within the criminal-legal system. This initiative focuses on enhancing research and effective interventions for individuals at risk of overdose during their transition through various stages of the justice system, with an emphasis on increasing access to medication for opioid use disorder (MOUD). The program will support multi-site studies, conduct cost analyses, and develop resources for practitioners, with a total funding amount of $800,000 allocated for one award. Interested applicants must submit their proposals by January 22, 2025, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional) to support research on effective interventions for individuals with substance use disorders (SUDs) within the criminal-legal system. This initiative aims to enhance the delivery of medication for opioid use disorder (MOUD) and address the overdose crisis by establishing multiple research centers that will collaborate with resource centers to improve treatment access and continuity of care for justice-involved populations. With a total funding budget of $5 million, the NIH plans to award five to seven grants, each with a maximum direct cost of $2.25 million, for projects lasting up to five years. Interested applicants must submit their proposals by January 22, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials," aimed at encouraging pilot research to develop and test interventions that prevent or delay substance use. The initiative focuses on the creation and pilot testing of new or adapted strategies to curb substance misuse, particularly among underserved populations, while also addressing related negative outcomes such as impaired driving and transmission of infectious diseases. Eligible applicants include a wide range of institutions, such as academic, nonprofit, and government organizations, with funding available up to $450,000 over three years. Interested parties should note that applications are due starting January 16, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Clinical Research Hubs, which requires a UM1 clinical trial. This initiative aims to address the opioid overdose crisis by researching effective interventions for individuals with substance use disorders (SUD) within the criminal justice system, focusing on optimizing treatment and enhancing collaboration between justice and community health agencies. The program anticipates funding 8-10 awards, with a total budget of approximately $14 million over five years, and emphasizes the importance of stakeholder engagement and diverse perspectives in the research process. Interested applicants must submit their proposals by January 22, 2025, and can find more information at the provided NIH grants link or contact NIH Grants Information at grantsinfo@nih.gov.
    HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the HEAL Initiative for the JCOIN Phase II Community Engaged Research Resource Center (CERRC), aimed at addressing the overdose crisis among individuals involved in the criminal-legal system. This initiative seeks to engage various stakeholders in researching effective interventions for substance use disorders (SUD) and enhancing continuity of care between public health and public safety agencies, with a focus on community engagement and diversity, equity, and inclusion (DEI). The funding, capped at $750,000 per year, is available for projects that include engaging individuals with lived experience, creating public resources for community-engaged research, and conducting rapid turnaround research projects, with applications due by January 23, 2025. For further information, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-026.html.